LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

Search

Kala Pharmaceuticals Inc

Gesloten

0.7 -6.67

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

0.7

Max

0.76

Belangrijke statistieken

By Trading Economics

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+985.53% upside

Dividenden

By Dow Jones

Volgende Winsten

10 nov 2025

Kala Pharmaceuticals Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

6 nov 2025, 23:38 UTC

Winsten

OCBC Posts Steady Third-Quarter Net Profit, Drop in Net Interest Income

6 nov 2025, 23:00 UTC

Winsten

Macquarie's First-Half Profit Grows 2.7%, Missing Forecasts -- Update

6 nov 2025, 22:19 UTC

Winsten
Belangrijke Marktbewegers

Block Shares Slide After 3Q Results Miss Estimates

6 nov 2025, 21:53 UTC

Winsten

Macquarie's First-Half Profit Grows 2.7%, Missing Forecasts

6 nov 2025, 23:45 UTC

Winsten

Wheaton Precious Metals 3Q Sales $476M >WPM

6 nov 2025, 23:45 UTC

Winsten

Wheaton Precious Metals 3Q Adj EPS 61.8c >WPM

6 nov 2025, 23:45 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

6 nov 2025, 23:45 UTC

Marktinformatie

Nikkei May Fall After U.S. Tech Stocks Drop

6 nov 2025, 23:45 UTC

Winsten

Wheaton Precious Metals 3Q EPS 80.7c >WPM

6 nov 2025, 23:38 UTC

Marktinformatie

Gold Edges Higher Amid Worrisome Signs for U.S. Economy -- Market Talk

6 nov 2025, 23:15 UTC

Winsten

Kakao 3Q Net Profit Beat FactSet-Compiled Consensus

6 nov 2025, 23:14 UTC

Winsten

Kakao 3Q Net KRW192.86B Vs. Net KRW78.51B >035720.SE

6 nov 2025, 23:14 UTC

Winsten

Kakao 3Q Oper Pft KRW208.05B Vs. Pft KRW130.53B >035720.SE

6 nov 2025, 23:13 UTC

Winsten

Kakao 3Q Rev KRW2.087T Vs. KRW1.921T >035720.SE

6 nov 2025, 23:08 UTC

Winsten

Oversea-Chinese Banking Corp. 3Q Total Income S$3.80B Vs. S$3.80B >O39.SG

6 nov 2025, 23:08 UTC

Winsten

Oversea-Chinese Banking Corp. 3Q Noninterest Income S$1.57B Vs. S$1.37B >O39.SG

6 nov 2025, 23:07 UTC

Winsten

Oversea-Chinese Banking Corp. 3Q Net S$1.98B Vs. Net S$1.97B >O39.SG

6 nov 2025, 23:07 UTC

Winsten

Suzano 3Q Rev BRL12.2B >SUZ

6 nov 2025, 22:47 UTC

Acquisities, Fusies, Overnames

Wheaton Precious Metals to Pay Waterton Gold $670M Up Front

6 nov 2025, 22:47 UTC

Acquisities, Fusies, Overnames

Wheaton Precious Metals to Buy Gold Stream on Spring Valley Project Located in Nevada >WPM

6 nov 2025, 22:45 UTC

Acquisities, Fusies, Overnames

Union Pacific and Norfolk Southern Provide Supplemental Disclosures to Joint Proxy Statement About Merger

6 nov 2025, 22:25 UTC

Acquisities, Fusies, Overnames

At Bank of America's Investor Day, M&A Hints, Would-Be CEOs, and AI Pitches -- Barrons.com

6 nov 2025, 22:13 UTC

Winsten

Fairfax Financial 3Q Rev $8.27B >FFH.T

6 nov 2025, 22:02 UTC

Winsten

Century Aluminum 3Q Sales $632.2M >CENX

6 nov 2025, 22:02 UTC

Winsten

Century Aluminum 3Q Adj EPS 56c >CENX

6 nov 2025, 21:53 UTC

Winsten

DraftKings Stock Sinks on Disappointing Results -- Barrons.com

6 nov 2025, 21:52 UTC

Acquisities, Fusies, Overnames

Universal Display: Portfolio Includes More Than 300 Issued and Pending Patents Worldwide, Covering More Than 110 Unique Patent Families >OLED

6 nov 2025, 21:51 UTC

Acquisities, Fusies, Overnames

Universal Display Corp to Acquire Emissive OLED Patent Assets From Merck KGaA, Darmstadt, Germany

6 nov 2025, 21:50 UTC

Marktinformatie
Winsten
Acquisities, Fusies, Overnames

Tech, Media & Telecom Roundup: Market Talk

6 nov 2025, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Kala Pharmaceuticals Inc Prognose

Koersdoel

By TipRanks

985.53% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 8.25 USD  985.53%

Hoogste 15 USD

Laagste 1.5 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Kala Pharmaceuticals Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

3 ratings

1

Buy

2

Hold

0

Sell

Financieel

$

Over Kala Pharmaceuticals Inc

Kala Pharmaceuticals Inc
help-icon Live chat